CIK 0001710340
- Non-accelerated filer
- Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371858472
- Phone
- +1 847-787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 4 Open-market sale 10% owner sold 126,685 shares at an average $37.64 ($4,768,637)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 50,000 shares at $32.48 ($1,623,795)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & CEO sold 120,000 shares at an average $31.88 ($3,825,717)
- 4 Open-market sale Chief Business Officer sold 100,000 shares at an average $32.30 ($3,229,923)
- 4 Exercise or conversion Director acquired 32,155 shares (option exercise)
- 4 Option exercise Director acquired 30,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 5,015 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,942 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,293 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 85 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 6,264 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,542 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 6,732 shares (to pay taxes)
Page 2 of 7 · 133 filings